Adamas Pharmaceuticals - Top 20 Biotech VC Deals of 2009

Company: Adamas Pharmaceuticals
Based: Emeryville, CA
Amount: $40 million

Investors: Aeris CAPITAL, DAG Ventures, MDV-Mohr Davidow Ventures and Northgate Capital

Scoop: Emeryville, CA-based Adamas Pharmaceuticals scooped up $40 million in Series D cash to fund a trio of development programs--including work on a combo antiviral therapy for the flu.

Adamas was founded in 2004 to address such health problems as Parkinson's disease and dementia, as well as infectious diseases like the flu. The company has three product candidates in development: ADS-8902, the flu therapy; ADS-5101, a once-daily extended release formulation of amantadine hydrochloride for Parkinson's and other disorders; and ADS-8703, a fixed-dose combination for dementia.